8.77
price up icon0.00%   0.00
after-market After Hours: 8.77
loading

Kalvista Pharmaceuticals Inc Stock (KALV) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
11.45%
33.15
29.75 29.09 31.73 26.95
Operating Income/Loss
11.45%
-33.15
-29.75 -29.09 -31.73 -26.95
Nonoperating Income/Loss
96.71%
4.123
2.096 3.776 5.423 5.642
Income/Loss From Continuing Operations Before Tax
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Income/Loss From Continuing Operations After Tax
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Net Income/Loss
4.98%
-29.03
-27.65 -25.32 -26.30 -21.30
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.46%
34.72
34.57 34.41 2.0805 28.28
Diluted Average Shares
0.46%
34.72
34.57 34.41 2.0805 28.28
Basic Earnings Per Share
5.00%
-0.84
-0.80 -0.74 -0.75 -0.75
Diluted Earnings Per Share
5.00%
-0.84
-0.80 -0.74 -0.75 -0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):